M. Peter Moore

3.8k total citations · 1 hit paper
36 papers, 2.0k citations indexed

About

M. Peter Moore is a scholar working on Obstetrics and Gynecology, Endocrinology, Diabetes and Metabolism and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M. Peter Moore has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Obstetrics and Gynecology, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M. Peter Moore's work include Pregnancy and preeclampsia studies (13 papers), Birth, Development, and Health (6 papers) and Gestational Diabetes Research and Management (6 papers). M. Peter Moore is often cited by papers focused on Pregnancy and preeclampsia studies (13 papers), Birth, Development, and Health (6 papers) and Gestational Diabetes Research and Management (6 papers). M. Peter Moore collaborates with scholars based in New Zealand, United Kingdom and United States. M. Peter Moore's co-authors include Janet Rowan, Malcolm Battin, William M. Hague, Wanzhen Gao, Christopher W.G. Redman, Joanna Gullam, Khadeeja Mohamed, Ruth Hughes, Helen Lunt and Stephen P. Gatt and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and Endocrinology.

In The Last Decade

M. Peter Moore

36 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metformin versus Insulin for the Treatment of Gestational Diabetes

2008 748 citations Janet Rowan, William M. Hague et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Peter Moore New Zealand	18	1.4k	717	562	361	227	36	2.0k
Graziano Di Cianni Italy	24	1.5k 1.1×	711 1.0×	691 1.2×	675 1.9×	197 0.9×	85	2.2k
Ewa Wender-Ożegowska Poland	21	926 0.6×	518 0.7×	269 0.5×	216 0.6×	165 0.7×	145	1.4k
Ute M. Schaefer-Graf Germany	22	1.6k 1.1×	942 1.3×	626 1.1×	282 0.8×	212 0.9×	39	1.9k
Kerstin Berntorp Sweden	29	1.0k 0.7×	483 0.7×	745 1.3×	915 2.5×	151 0.7×	87	2.4k
Donald Pearson United Kingdom	16	556 0.4×	302 0.4×	446 0.8×	855 2.4×	108 0.5×	28	1.7k
Nam H. Cho South Korea	25	1.3k 0.9×	877 1.2×	639 1.1×	675 1.9×	278 1.2×	43	2.4k
Katrien Benhalima Belgium	26	1.3k 0.9×	478 0.7×	917 1.6×	617 1.7×	142 0.6×	91	2.0k
Jens Fuglsang Denmark	18	681 0.5×	392 0.5×	250 0.4×	270 0.7×	141 0.6×	64	1.2k
Eszter Vanky Norway	30	1.3k 0.9×	823 1.1×	269 0.5×	322 0.9×	1.2k 5.3×	111	2.9k
Arianne Sweeting Australia	17	1.1k 0.8×	476 0.7×	474 0.8×	235 0.7×	125 0.6×	51	1.5k

Countries citing papers authored by M. Peter Moore

Since Specialization

Citations

This map shows the geographic impact of M. Peter Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Peter Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Peter Moore more than expected).

Fields of papers citing papers by M. Peter Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Peter Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Peter Moore. The network helps show where M. Peter Moore may publish in the future.

Co-authorship network of co-authors of M. Peter Moore

This figure shows the co-authorship network connecting the top 25 collaborators of M. Peter Moore. A scholar is included among the top collaborators of M. Peter Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Peter Moore. M. Peter Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doogue, Matthew, Evan J. Begg, M. Peter Moore, et al.. (2009). Metformin increases plasma ghrelin in Type 2 diabetes. British Journal of Clinical Pharmacology. 68(6). 875–882. 29 indexed citations

Löwe, Sandra, Mark Brown, Gustaaf Dekker, et al.. (2009). Guidelines for the management of hypertensive disorders of pregnancy 2008. Australian and New Zealand Journal of Obstetrics and Gynaecology. 49(3). 242–246. 231 indexed citations

Rowan, Janet, William M. Hague, Wanzhen Gao, Malcolm Battin, & M. Peter Moore. (2008). Metformin versus Insulin for the Treatment of Gestational Diabetes. New England Journal of Medicine. 358(19). 2003–2015. 748 indexed citations breakdown →

Horwood, L. John, et al.. (2008). Comparison of methods to identify significant proteinuria in pregnancy in the outpatient setting. BJOG An International Journal of Obstetrics & Gynaecology. 115(4). 523–527. 31 indexed citations

Menzies, Jennifer, Laura A. Magee, Ying C. MacNab, et al.. (2007). Current CHS and NHBPEP Criteria for Severe Preeclampsia Do Not Uniformly Predict Adverse Maternal or Perinatal Outcomes. Hypertension in Pregnancy. 26(4). 447–462. 89 indexed citations

Moore, M. Peter, et al.. (2004). Treatment satisfaction after commencement of insulin in Type 2 diabetes. Diabetes Research and Clinical Practice. 66(3). 263–267. 29 indexed citations

Lunt, Helen, Deborah Kendall, M. Peter Moore, et al.. (2004). Prospective audit of conversion from regular to lispro insulin during routine clinical care. Internal Medicine Journal. 34(6). 320–323. 3 indexed citations

Gardiner, Sharon J., Carl M. J. Kirkpatrick, Evan J. Begg, et al.. (2003). Transfer of metformin into human milk. Clinical Pharmacology & Therapeutics. 73(1). 71–77. 58 indexed citations

Moore, M. Peter & Helen Lunt. (2000). Diabetes in New Zealand. Diabetes Research and Clinical Practice. 50. S65–S71. 21 indexed citations

10.

Kaaja, Risto, M. Peter Moore, Timothy G. Yandle, et al.. (1999). Blood Pressure and Vasoactive Hormones in Mild Preeclampsia and Normal Pregnancy. Hypertension in Pregnancy. 18(2). 173–187. 44 indexed citations

11.

Colman, Peter G., et al.. (1999). New classification and criteria for diagnosis of diabetes mellitus. The Australasian Working Party on Diagnostic Criteria for Diabetes Mellitus.. PubMed. 112(1086). 139–41. 27 indexed citations

12.

Thomas, Philip, Hari Sundaram, Belinda J. Krishek, et al.. (1997). Regulation of Neuronal and Recombinant GABAA Receptor Ion Channels by Xenovulene A, a Natural Product Isolated from Acremonium strictum. Journal of Pharmacology and Experimental Therapeutics. 282(2). 513–520. 6 indexed citations

13.

Keegan, Robert D., et al.. (1993). Antagonism by flumazenil of midazolam-induced changes in quantitative electroencephalographic data from isofluraneanesthetized dogs. American Journal of Veterinary Research. 54(5). 761–765. 7 indexed citations

14.

Greene, Stephen A., et al.. (1992). Quantitative electroencephalography for measurement of central nervous system responses to diazepam and the benzodiazepine antagonist, flumazenil, in isoflurane‐anaesthetized dogs. Journal of Veterinary Pharmacology and Therapeutics. 15(3). 259–266. 8 indexed citations

15.

Moore, M. Peter, et al.. (1988). Hormonal and Metabolic Effects of Enalapril Treatment in Hypertensive Subjects With NIDDM. Diabetes Care. 11(5). 397–401. 21 indexed citations

16.

Aronson, Jeffrey K, M. Peter Moore, C.W.G. Redman, & Charlie Harper. (1984). Erythrocytic cation transport receptor numbers and activity in pregnancies complicated by essential hypertension and pre-eclampsia.. BMJ. 288(6427). 1332–1334. 12 indexed citations

17.

Moore, M. Peter & Christopher W.G. Redman. (1983). Case-control study of severe pre-eclampsia of early onset.. BMJ. 287(6392). 580–583. 106 indexed citations

18.

Moore, M. Peter, et al.. (1983). Lymphocyte subsets in normal and pre‐eclamptic pregnancies. BJOG An International Journal of Obstetrics & Gynaecology. 90(4). 326–331. 28 indexed citations

19.

Moore, M. Peter & Christopher W.G. Redman. (1982). The treatment of hypertension in pregnancy. Current Medical Research and Opinion. 8(sup1). 39–46. 14 indexed citations

20.

Mayer, Gaétan, et al.. (1979). Effect of Epinephrine on Parathyroid Hormone Secretion in Calves. Endocrinology. 104(4). 1181–1187. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact